Although these small molecule inhibitors of CD38 have not been reported in the literature for their use in tumor treatment, we strongly believe that these inhibitors will at least become powerful tools for unveiling the role of the enzymatic function of CD38 in tumors and solid TME. The gene discussed is CD38; the disease is neoplasm.